Mostrar el registro sencillo del ítem

Immunomodulation of Osseointegration Through Extracorporeal Shock Wave Therapy

dc.contributor.authorAmengual-Penafiel L.
dc.contributor.authorJara-Sepúlveda M.
dc.contributor.authorParada-Pozas L.
dc.contributor.authorMarchesani-Carrasco F.
dc.contributor.authorCartes-Velásquez R.
dc.contributor.authorGaldames-Gutiérrez B.
dc.date.accessioned2020-09-02T22:11:14Z
dc.date.available2020-09-02T22:11:14Z
dc.date.issued2018
dc.identifier10.4103/denthyp.denthyp_4_18
dc.identifier.citation9, 2, 45-50
dc.identifier.issn21558213
dc.identifier.urihttps://hdl.handle.net/20.500.12728/3561
dc.descriptionIntroduction: Dental implants are a routine procedure within the therapeutic range of dentists. Many loading protocols are based on techniques and biological times that consider the biology of the host bed. However, early or late complications may occur, such as lack of osseointegration, peri-implantitis, and marginal bone loss. Nowadays, treatments for total or partial failure in osseointegration are often complex and unpredictable. It has recently been postulated that osseointegration is rather an immunomodulated event, which is the result of an equilibrium response to a foreign body reaction. Given this new evidence, there is a need to develop new therapeutic protocols and approaches to improve osseointegration and the prognosis of implant treatments. Hypothesis: Human bone marrow-derived mesenchymal stem cells (HBMMSC), resident in the maxillary and mandibular bones, immunomodulate osseointegration through the bioactivating effect of extracorporeal shock waves therapy (ESWT). Evaluation of the Hypothesis: Local immunomodulation is currently considered one of the main functions of mesenchymal stem cells to maintain tissue homeostasis, and it has been demonstrated that ESWT manages to stimulate the activity of HBMMSC. Clinical and experimental reports demonstrate the therapeutic potential of ESWT in medicine and dentistry. Conclusion: ESWT medical devices could become a new therapeutic strategy to immunomodulate osseointegration. The bioactivating effect of ESWT on resident HBMMSC can have the potential of guiding the tissue response to a more favorable outcome, with the objective of improving clinical success and decreasing the complications of dental implant treatments. © 2018 Medknow Publications. All rights reserved.
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.subjectESWT
dc.subjectHBMMSC
dc.subjectimmunomodulation
dc.subjectosseointegration
dc.titleImmunomodulation of Osseointegration Through Extracorporeal Shock Wave Therapy
dc.typeArticle


Ficheros en el ítem

Thumbnail
Nombre:
item_2-s2.0-85055718825.pdf
Tamaño:
2.814Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem